Fount
Fount is a human performance R&D company that aims to optimize physiology for better thinking, feeling, and performance. Founded by Andrew Herr, who has extensive experience with the U.S. military and elite athletes, Fount provides advanced personalization and protocols that were previously available only to pro athletes and military organizations. Their flagship product, Fly Kitt, is a comprehensive jet lag solution that combines patented supplements, specialized glasses, and an AI-driven app to help travelers sync their circadian rhythms and enhance recovery, making it a trusted choice for athletes and military units alike.
Fount
Fount is a human performance R&D company that aims to optimize physiology for better thinking, feeling, and performance. Founded by Andrew Herr, who has extensive experience with the U.S. military and elite athletes, Fount provides advanced personalization and protocols that were previously available only to pro athletes and military organizations. Their flagship product, Fly Kitt, is a comprehensive jet lag solution that combines patented supplements, specialized glasses, and an AI-driven app to help travelers sync their circadian rhythms and enhance recovery, making it a trusted choice for athletes and military units alike.
TL;DR
Core product: FlyKitt jet-lag prevention & recovery system (supplements, Unwind glasses, AI app)
Founder & CEO: Andrew Herr
Headcount: 14 employees
Notable funding: $12.0M Series A (Mar 2023)
Target customers: Professional athletes, military units, business travelers
Company Overview
Problem Domain
Travel-related circadian disruption (jet lag), recovery, and performance optimization
Industry
Consumer health / human performance
Funding Track Record
$12.0M
Reported March 2023; named participants in the round include Elysian Park Ventures, Allen & Company, Amity Ventures, Champion Hill Ventures, and Not Boring Capital
Investor Signal
“Elysian Park Ventures; Allen & Company; Amity Ventures; Champion Hill Ventures; Not Boring Capital”